25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Amedisys Inc
Buy, Hold or Sell?

Let's analyze Amedisys together

I guess you are interested in Amedisys Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Amedisys Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Amedisys Inc

I send you an email if I find something interesting about Amedisys Inc.

1. Quick Overview

1.1. Quick analysis of Amedisys (30 sec.)










1.2. What can you expect buying and holding a share of Amedisys? (30 sec.)

How much money do you get?

How much money do you get?
€0.00
When do you have the money?
1 year
How often do you get paid?
15.4%

What is your share worth?

Current worth
€35.27
Expected worth in 1 year
€38.41
How sure are you?
92.3%

+ What do you gain per year?

Total Gains per Share
€3.14
Return On Investment
3.6%

For what price can you sell your share?

Current Price per Share
€87.50
Expected price per share
€79.00 - €
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Amedisys (5 min.)




Live pricePrice per Share (EOD)
€87.50
Intrinsic Value Per Share
€90.37 - €107.17
Total Value Per Share
€125.64 - €142.44

2.2. Growth of Amedisys (5 min.)




Is Amedisys growing?

Current yearPrevious yearGrowGrow %
How rich?$1.2b$1b$61.8m5.3%

How much money is Amedisys making?

Current yearPrevious yearGrowGrow %
Making money$20.7m$662k$20m96.8%
Net Profit Margin3.6%0.1%--

How much money comes from the company's main activities?

2.3. Financial Health of Amedisys (5 min.)




2.4. Comparing to competitors in the Medical Care Facilities industry (5 min.)




  Industry Rankings (Medical Care Facilities)  


Richest
#24 / 177

Most Revenue
#36 / 177

Most Profit
#33 / 177
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Amedisys?

Welcome investor! Amedisys's management wants to use your money to grow the business. In return you get a share of Amedisys.

First you should know what it really means to hold a share of Amedisys. And how you can make/lose money.

Speculation

The Price per Share of Amedisys is €87.50. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Amedisys.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Amedisys, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €35.27. Based on the TTM, the Book Value Change Per Share is €0.79 per quarter. Based on the YOY, the Book Value Change Per Share is €0.18 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Amedisys.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps0.520.6%0.630.7%0.020.0%0.901.0%0.921.1%
Usd Book Value Change Per Share0.660.8%0.820.9%0.180.2%0.911.0%1.411.6%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.660.8%0.820.9%0.180.2%0.911.0%1.411.6%
Usd Price Per Share88.32-88.19-81.18-136.69-129.27-
Price to Earnings Ratio42.77-38.11-15.65-31.95-30.80-
Price-to-Total Gains Ratio134.22-112.44-51.56-87.76-85.63-
Price to Book Ratio2.41-2.49-2.43-5.09-5.48-
Price-to-Total Gains Ratio134.22-112.44-51.56-87.76-85.63-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share90.92125
Number of shares10
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.820.91
Usd Total Gains Per Share0.820.91
Gains per Quarter (10 shares)8.169.14
Gains per Year (10 shares)32.6436.58
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10332303627
20655607364
3098890109101
401311221146138
501631551182175
601961881219212
702292211255249
802612541292286
902942871328323
1003263201365360

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%11.01.00.091.7%19.01.00.095.0%25.01.00.096.2%25.01.00.096.2%
Book Value Change Per Share4.00.00.0100.0%11.01.00.091.7%18.02.00.090.0%24.02.00.092.3%24.02.00.092.3%
Dividend per Share0.00.04.00.0%0.00.012.00.0%4.00.016.020.0%4.00.022.015.4%4.00.022.015.4%
Total Gains per Share4.00.00.0100.0%11.01.00.091.7%18.02.00.090.0%24.02.00.092.3%24.02.00.092.3%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Amedisys Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.6330.785-19%0.176+261%0.877-28%1.357-53%
Book Value Per Share--35.27234.096+3%32.278+9%28.450+24%25.303+39%
Current Ratio--1.1931.122+6%1.041+15%1.029+16%1.023+17%
Debt To Asset Ratio--0.4390.448-2%0.446-2%0.475-8%0.472-7%
Debt To Equity Ratio--0.8180.851-4%0.849-4%0.944-13%0.933-12%
Dividend Per Share----0%-0%0.003-100%0.002-100%
Enterprise Value--1880751680.0001874236690.900+0%1707503536.300+10%3475233131.580-46%3331033618.785-44%
Eps--0.4970.609-18%0.019+2455%0.871-43%0.886-44%
Ev To Ebitda Ratio--infinfnan%infnan%infnan%infnan%
Ev To Sales Ratio--0.8310.839-1%0.797+4%1.667-50%1.660-50%
Free Cash Flow Per Share--3.0571.495+104%0.772+296%1.333+129%1.333+129%
Free Cash Flow To Equity Per Share--2.6131.119+133%0.108+2323%1.155+126%1.155+126%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--107.165--------
Intrinsic Value_10Y_min--90.370--------
Intrinsic Value_1Y_max--4.911--------
Intrinsic Value_1Y_min--4.821--------
Intrinsic Value_3Y_max--19.197--------
Intrinsic Value_3Y_min--18.238--------
Intrinsic Value_5Y_max--38.838--------
Intrinsic Value_5Y_min--35.666--------
Market Cap2866018750.000+3%2784132500.0002780038187.500+0%2558945312.500+9%4310041556.100-35%4075875288.538-32%
Net Profit Margin--0.0290.036-19%0.001+3384%0.054-47%0.058-50%
Operating Margin----0%0.036-100%0.072-100%0.081-100%
Operating Ratio--1.4941.473+1%1.470+2%1.469+2%1.475+1%
Pb Ratio2.481+3%2.4102.491-3%2.426-1%5.086-53%5.483-56%
Pe Ratio44.024+3%42.76738.107+12%15.652+173%31.953+34%30.803+39%
Price Per Share87.500+3%85.00084.875+0%78.125+9%131.550-35%124.409-32%
Price To Free Cash Flow Ratio7.157+3%6.952-10.642+253%-3.368+148%33.910-79%26.085-73%
Price To Total Gains Ratio138.171+3%134.223112.444+19%51.565+160%87.758+53%85.627+57%
Quick Ratio--0.6190.691-10%0.747-17%0.697-11%0.731-15%
Return On Assets--0.0080.010-20%0.000+2284%0.017-54%0.021-63%
Return On Equity--0.0150.019-21%0.000+102%0.035-57%0.041-64%
Total Gains Per Share--0.6330.785-19%0.176+261%0.880-28%1.359-53%
Usd Book Value--1200474821.1001160475127.545+3%1098581780.702+9%968438897.354+24%861294815.655+39%
Usd Book Value Change Per Share--0.6580.816-19%0.182+261%0.911-28%1.410-53%
Usd Book Value Per Share--36.65135.429+3%33.540+9%29.563+24%26.292+39%
Usd Dividend Per Share----0%-0%0.003-100%0.002-100%
Usd Enterprise Value--1954289070.6881947519345.514+0%1774266924.569+10%3611114747.025-46%3461277033.279-44%
Usd Eps--0.5160.633-18%0.020+2455%0.905-43%0.921-44%
Usd Free Cash Flow--104032104.22550885518.379+104%26281284.210+296%43105436.228+141%33158027.868+214%
Usd Free Cash Flow Per Share--3.1761.554+104%0.802+296%1.385+129%1.385+129%
Usd Free Cash Flow To Equity Per Share--2.7151.163+133%0.112+2323%1.200+126%1.200+126%
Usd Market Cap2978080083.125+3%2892992080.7502888737680.631+0%2659000074.219+9%4478564180.944-35%4235242012.320-32%
Usd Price Per Share90.921+3%88.32488.194+0%81.180+9%136.694-35%129.274-32%
Usd Profit--16911504.62420734118.688-18%662019.754+2455%29641334.471-43%30161438.452-44%
Usd Revenue--587688536.103580282315.108+1%556931118.329+6%549824506.274+7%527493932.257+11%
Usd Total Gains Per Share--0.6580.816-19%0.182+261%0.914-28%1.412-53%
 EOD+4 -4MRQTTM+19 -16YOY+30 -65Y+16 -2210Y+16 -22

3.3 Fundamental Score

Let's check the fundamental score of Amedisys Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1544.024
Price to Book Ratio (EOD)Between0-12.481
Net Profit Margin (MRQ)Greater than00.029
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.619
Current Ratio (MRQ)Greater than11.193
Debt to Asset Ratio (MRQ)Less than10.439
Debt to Equity Ratio (MRQ)Less than10.818
Return on Equity (MRQ)Greater than0.150.015
Return on Assets (MRQ)Greater than0.050.008
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of Amedisys Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5053.683
Ma 20Greater thanMa 5087.725
Ma 50Greater thanMa 10084.700
Ma 100Greater thanMa 20085.595
OpenGreater thanClose87.500
Total2/5 (40.0%)

4. In-depth Analysis

4.1 About Amedisys Inc

Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients. The Hospice segment offers services that is designed to provide comfort and support for those who are dealing with a terminal illness, including cancer, heart disease, pulmonary disease, or Alzheimer's. The High Acuity Care offers essential elements of inpatient hospital, skilled nursing facility care, and palliative care to patients in their homes. Amedisys, Inc. was incorporated in 1982 and is headquartered in Baton Rouge, Louisiana.

Fundamental data was last updated by Penke on 2025-01-11 22:32:04.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is inefficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Amedisys earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Amedisys to the Medical Care Facilities industry mean.
  • A Net Profit Margin of 2.9% means that €0.03 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Amedisys Inc:

  • The MRQ is 2.9%. The company is making a profit. +1
  • The TTM is 3.6%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ2.9%TTM3.6%-0.7%
TTM3.6%YOY0.1%+3.5%
TTM3.6%5Y5.4%-1.9%
5Y5.4%10Y5.8%-0.4%
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ2.9%4.8%-1.9%
TTM3.6%3.3%+0.3%
YOY0.1%2.7%-2.6%
5Y5.4%3.2%+2.2%
10Y5.8%3.7%+2.1%
4.3.1.2. Return on Assets

Shows how efficient Amedisys is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Amedisys to the Medical Care Facilities industry mean.
  • 0.8% Return on Assets means that Amedisys generated €0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Amedisys Inc:

  • The MRQ is 0.8%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is 1.0%. Using its assets, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ0.8%TTM1.0%-0.2%
TTM1.0%YOY0.0%+1.0%
TTM1.0%5Y1.7%-0.8%
5Y1.7%10Y2.1%-0.4%
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8%1.4%-0.6%
TTM1.0%1.2%-0.2%
YOY0.0%0.8%-0.8%
5Y1.7%1.2%+0.5%
10Y2.1%1.0%+1.1%
4.3.1.3. Return on Equity

Shows how efficient Amedisys is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Amedisys to the Medical Care Facilities industry mean.
  • 1.5% Return on Equity means Amedisys generated €0.01 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Amedisys Inc:

  • The MRQ is 1.5%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 1.9%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ1.5%TTM1.9%-0.4%
TTM1.9%YOY0.0%+1.9%
TTM1.9%5Y3.5%-1.6%
5Y3.5%10Y4.1%-0.7%
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ1.5%3.6%-2.1%
TTM1.9%3.1%-1.2%
YOY0.0%2.2%-2.2%
5Y3.5%2.6%+0.9%
10Y4.1%3.0%+1.1%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Amedisys Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Amedisys is operating .

  • Measures how much profit Amedisys makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Amedisys to the Medical Care Facilities industry mean.
  • An Operating Margin of 0.0% means the company generated €0.00  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Amedisys Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY3.6%-3.6%
TTM-5Y7.2%-7.2%
5Y7.2%10Y8.1%-0.9%
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ-7.9%-7.9%
TTM-6.8%-6.8%
YOY3.6%8.1%-4.5%
5Y7.2%6.9%+0.3%
10Y8.1%7.8%+0.3%
4.3.2.2. Operating Ratio

Measures how efficient Amedisys is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Care Facilities industry mean).
  • An Operation Ratio of 1.49 means that the operating costs are €1.49 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Amedisys Inc:

  • The MRQ is 1.494. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.473. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.494TTM1.473+0.021
TTM1.473YOY1.470+0.003
TTM1.4735Y1.469+0.005
5Y1.46910Y1.475-0.007
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ1.4941.000+0.494
TTM1.4731.024+0.449
YOY1.4700.980+0.490
5Y1.4690.979+0.490
10Y1.4750.966+0.509
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Amedisys Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Amedisys is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Care Facilities industry mean).
  • A Current Ratio of 1.19 means the company has €1.19 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Amedisys Inc:

  • The MRQ is 1.193. The company is just able to pay all its short-term debts.
  • The TTM is 1.122. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.193TTM1.122+0.072
TTM1.122YOY1.041+0.081
TTM1.1225Y1.029+0.093
5Y1.02910Y1.023+0.006
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ1.1931.245-0.052
TTM1.1221.251-0.129
YOY1.0411.316-0.275
5Y1.0291.390-0.361
10Y1.0231.443-0.420
4.4.3.2. Quick Ratio

Measures if Amedisys is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Amedisys to the Medical Care Facilities industry mean.
  • A Quick Ratio of 0.62 means the company can pay off €0.62 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Amedisys Inc:

  • The MRQ is 0.619. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.691. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.619TTM0.691-0.072
TTM0.691YOY0.747-0.056
TTM0.6915Y0.697-0.006
5Y0.69710Y0.731-0.033
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6190.841-0.222
TTM0.6910.839-0.148
YOY0.7471.027-0.280
5Y0.6971.165-0.468
10Y0.7311.190-0.459
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Amedisys Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Amedisys assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Amedisys to Medical Care Facilities industry mean.
  • A Debt to Asset Ratio of 0.44 means that Amedisys assets are financed with 43.9% credit (debt) and the remaining percentage (100% - 43.9%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Amedisys Inc:

  • The MRQ is 0.439. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.448. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.439TTM0.448-0.009
TTM0.448YOY0.446+0.002
TTM0.4485Y0.475-0.027
5Y0.47510Y0.472+0.003
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4390.514-0.075
TTM0.4480.522-0.074
YOY0.4460.530-0.084
5Y0.4750.545-0.070
10Y0.4720.528-0.056
4.5.4.2. Debt to Equity Ratio

Measures if Amedisys is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Amedisys to the Medical Care Facilities industry mean.
  • A Debt to Equity ratio of 81.8% means that company has €0.82 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Amedisys Inc:

  • The MRQ is 0.818. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.851. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.818TTM0.851-0.033
TTM0.851YOY0.849+0.002
TTM0.8515Y0.944-0.093
5Y0.94410Y0.933+0.010
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8180.955-0.137
TTM0.8510.975-0.124
YOY0.8490.996-0.147
5Y0.9441.153-0.209
10Y0.9331.235-0.302
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Amedisys generates.

  • Above 15 is considered overpriced but always compare Amedisys to the Medical Care Facilities industry mean.
  • A PE ratio of 42.77 means the investor is paying €42.77 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Amedisys Inc:

  • The EOD is 44.024. Based on the earnings, the company is overpriced. -1
  • The MRQ is 42.767. Based on the earnings, the company is overpriced. -1
  • The TTM is 38.107. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD44.024MRQ42.767+1.258
MRQ42.767TTM38.107+4.660
TTM38.107YOY15.652+22.455
TTM38.1075Y31.953+6.154
5Y31.95310Y30.803+1.150
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
EOD44.02412.499+31.525
MRQ42.76712.677+30.090
TTM38.10713.741+24.366
YOY15.65214.704+0.948
5Y31.95318.621+13.332
10Y30.80321.910+8.893
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Amedisys Inc:

  • The EOD is 7.157. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 6.952. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is -10.642. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD7.157MRQ6.952+0.204
MRQ6.952TTM-10.642+17.594
TTM-10.642YOY-3.368-7.274
TTM-10.6425Y33.910-44.552
5Y33.91010Y26.085+7.825
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
EOD7.1578.830-1.673
MRQ6.9529.416-2.464
TTM-10.6427.737-18.379
YOY-3.3687.427-10.795
5Y33.9107.029+26.881
10Y26.0856.926+19.159
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Amedisys is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Care Facilities industry mean).
  • A PB ratio of 2.41 means the investor is paying €2.41 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Amedisys Inc:

  • The EOD is 2.481. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.410. Based on the equity, the company is underpriced. +1
  • The TTM is 2.491. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD2.481MRQ2.410+0.071
MRQ2.410TTM2.491-0.081
TTM2.491YOY2.426+0.065
TTM2.4915Y5.086-2.595
5Y5.08610Y5.483-0.398
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
EOD2.4811.765+0.716
MRQ2.4101.889+0.521
TTM2.4911.978+0.513
YOY2.4262.098+0.328
5Y5.0862.365+2.721
10Y5.4832.710+2.773
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-09-30. Currency in USD. All numbers in thousands.

Summary
Total Assets2,139,114
Total Liabilities938,675
Total Stockholder Equity1,147,764
 As reported
Total Liabilities 938,675
Total Stockholder Equity+ 1,147,764
Total Assets = 2,139,114

Assets

Total Assets2,139,114
Total Current Assets579,947
Long-term Assets1,559,167
Total Current Assets
Cash And Cash Equivalents 245,450
Net Receivables 301,050
Other Current Assets 12,962
Total Current Assets  (as reported)579,947
Total Current Assets  (calculated)559,462
+/- 20,485
Long-term Assets
Property Plant Equipment 127,110
Goodwill 1,244,679
Intangible Assets 99,698
Long-term Assets Other 87,680
Long-term Assets  (as reported)1,559,167
Long-term Assets  (calculated)1,559,167
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities486,021
Long-term Liabilities452,654
Total Stockholder Equity1,147,764
Total Current Liabilities
Short Long Term Debt 37,478
Accounts payable 32,117
Other Current Liabilities 106,000
Total Current Liabilities  (as reported)486,021
Total Current Liabilities  (calculated)175,595
+/- 310,426
Long-term Liabilities
Long term Debt 344,428
Capital Lease Obligations Min Short Term Debt85,764
Long-term Liabilities Other 886
Long-term Liabilities  (as reported)452,654
Long-term Liabilities  (calculated)431,078
+/- 21,576
Total Stockholder Equity
Retained Earnings 811,537
Total Stockholder Equity (as reported)1,147,764
Total Stockholder Equity (calculated)811,537
+/- 336,227
Other
Capital Stock38
Common Stock Shares Outstanding 32,751
Net Debt 136,456
Net Invested Capital 1,529,670
Net Working Capital 93,926
Property Plant and Equipment Gross 228,113



6.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-30
> Total Assets 
753,324
725,892
717,118
1,184,239
1,205,862
1,212,380
1,262,745
1,440,084
1,645,488
1,602,720
1,567,198
1,573,209
1,599,563
1,937,645
1,856,968
1,908,392
2,000,986
1,982,127
1,976,245
1,946,959
1,982,402
2,027,417
2,060,170
2,089,871
2,117,368
2,139,114
2,139,1142,117,3682,089,8712,060,1702,027,4171,982,4021,946,9591,976,2451,982,1272,000,9861,908,3921,856,9681,937,6451,599,5631,573,2091,567,1981,602,7201,645,4881,440,0841,262,7451,212,3801,205,8621,184,239717,118725,892753,324
   > Total Current Assets 
258,773
232,668
224,118
271,731
275,785
299,519
350,554
468,128
449,540
411,250
361,984
380,450
390,965
432,882
356,684
392,485
394,869
388,780
388,961
405,557
426,544
467,227
496,935
526,448
555,902
579,947
579,947555,902526,448496,935467,227426,544405,557388,961388,780394,869392,485356,684432,882390,965380,450361,984411,250449,540468,128350,554299,519275,785271,731224,118232,668258,773
       Cash And Cash Equivalents 
25,904
14,010
20,229
10,554
13,902
20,757
30,294
174,756
177,278
112,904
81,808
77,344
91,646
124,458
42,694
67,834
26,566
17,956
40,540
49,436
95,377
78,112
126,450
108,234
149,883
245,450
245,450149,883108,234126,45078,11295,37749,43640,54017,95626,56667,83442,694124,45891,64677,34481,808112,904177,278174,75630,29420,75713,90210,55420,22914,01025,904
       Net Receivables 
197,592
195,030
192,472
236,437
239,674
254,703
241,596
268,551
249,030
250,777
257,645
275,632
278,216
274,570
287,061
293,579
305,413
302,470
309,185
294,122
278,785
319,580
313,373
359,359
356,909
301,050
301,050356,909359,359313,373319,580278,785294,122309,185302,470305,413293,579287,061274,570278,216275,632257,645250,777249,030268,551241,596254,703239,674236,437192,472195,030197,592
       Other Current Assets 
24,784
11,949
3,849
13,948
13,252
13,458
70,421
12,334
12,444
32,663
12,314
12,025
9,124
17,774
16,573
13,851
47,691
51,343
27,608
43,245
22,824
33,097
8,260
26,053
26,125
12,962
12,96226,12526,0538,26033,09722,82443,24527,60851,34347,69113,85116,57317,7749,12412,02512,31432,66312,44412,33470,42113,45813,25213,9483,84911,94924,784
   > Long-term Assets 
0
0
0
912,508
930,077
912,861
912,179
971,956
1,195,948
1,191,470
1,205,214
1,192,759
1,208,598
1,504,763
1,500,284
1,515,907
1,606,117
1,593,347
1,587,284
1,541,402
1,555,858
1,560,190
1,605,038
1,563,423
1,561,466
1,559,167
1,559,1671,561,4661,563,4231,605,0381,560,1901,555,8581,541,4021,587,2841,593,3471,606,1171,515,9071,500,2841,504,7631,208,5981,192,7591,205,2141,191,4701,195,948971,956912,179912,861930,077912,508000
       Property Plant Equipment 
27,998
30,215
29,449
112,780
114,788
114,093
112,904
110,170
117,911
118,377
117,159
116,299
116,020
120,409
119,692
120,096
125,570
123,091
118,882
118,564
121,541
127,465
172,584
131,109
129,346
127,110
127,110129,346131,109172,584127,465121,541118,564118,882123,091125,570120,096119,692120,409116,020116,299117,159118,377117,911110,170112,904114,093114,788112,78029,44930,21527,998
       Goodwill 
324,145
324,145
329,480
649,514
664,822
660,472
658,500
721,049
937,088
931,483
932,685
933,207
936,772
1,188,054
1,196,090
1,204,638
1,289,672
1,285,455
1,287,399
1,244,679
1,244,679
1,244,679
1,244,679
1,244,679
1,244,679
1,244,679
1,244,6791,244,6791,244,6791,244,6791,244,6791,244,6791,244,6791,287,3991,285,4551,289,6721,204,6381,196,0901,188,054936,772933,207932,685931,483937,088721,049658,500660,472664,822649,514329,480324,145324,145
       Long Term Investments 
0
31,900
35,145
35,700
39,400
35,400
35,700
0
0
0
14,200
0
0
0
53,100
0
0
0
60,500
0
0
0
66,100
0
0
0
00066,10000060,50000053,10000014,20000035,70035,40039,40035,70035,14531,9000
       Intangible Assets 
44,888
44,309
44,132
62,801
61,966
66,468
64,748
68,251
81,813
84,143
74,183
69,764
66,432
118,084
111,190
106,534
106,189
103,678
101,167
99,929
104,744
103,634
102,675
101,778
100,832
99,698
99,698100,832101,778102,675103,634104,74499,929101,167103,678106,189106,534111,190118,08466,43269,76474,18384,14381,81368,25164,74866,46861,96662,80144,13244,30944,888
       Long-term Assets Other 
0
0
0
54,888
58,288
54,260
3,600
52,287
33,673
33,278
33,200
32,913
64,103
68,105
73,023
84,639
84,686
81,123
79,836
78,230
84,894
84,412
2,700
85,857
86,609
87,680
87,68086,60985,8572,70084,41284,89478,23079,83681,12384,68684,63973,02368,10564,10332,91333,20033,27833,67352,2873,60054,26058,28854,888000
> Total Liabilities 
344,263
280,396
234,485
663,039
642,920
608,915
621,232
759,940
923,229
844,977
756,457
783,635
723,676
988,844
880,645
887,740
961,991
912,517
869,672
813,611
921,645
933,899
940,387
947,217
938,482
938,675
938,675938,482947,217940,387933,899921,645813,611869,672912,517961,991887,740880,645988,844723,676783,635756,457844,977923,229759,940621,232608,915642,920663,039234,485280,396344,263
   > Total Current Liabilities 
214,189
219,290
222,476
297,377
313,007
314,653
326,943
316,106
442,048
437,496
456,337
456,082
449,223
454,349
374,282
380,154
427,372
367,200
355,529
353,050
462,401
468,119
473,721
484,860
479,976
486,021
486,021479,976484,860473,721468,119462,401353,050355,529367,200427,372380,154374,282454,349449,223456,082456,337437,496442,048316,106326,943314,653313,007297,377222,476219,290214,189
       Short-term Debt 
668
1,209
1,612
6,038
7,610
7,259
8,227
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000008,2277,2597,6106,0381,6121,209668
       Short Long Term Debt 
668
1,209
1,612
6,038
7,610
7,259
8,227
11,122
10,718
10,711
10,496
10,329
10,160
13,225
12,995
12,309
12,521
12,628
15,496
26,958
31,465
35,364
36,314
37,232
37,747
37,478
37,47837,74737,23236,31435,36431,46526,95815,49612,62812,52112,30912,99513,22510,16010,32910,49610,71110,71811,1228,2277,2597,6106,0381,6121,209668
       Accounts payable 
29,810
24,519
28,531
32,797
35,690
35,901
31,259
31,147
33,383
39,037
42,674
38,865
36,668
41,649
38,217
36,621
43,509
45,527
43,735
40,017
38,557
34,555
28,237
36,249
26,626
32,117
32,11726,62636,24928,23734,55538,55740,01743,73545,52743,50936,62138,21741,64936,66838,86542,67439,03733,38331,14731,25935,90135,69032,79728,53124,51929,810
       Other Current Liabilities 
1,100
8,100
26,300
11,700
10,200
11,800
52,300
12,000
95,600
93,400
138,100
71,600
68,328
67,135
57,000
0
4,200
10,600
63,200
0
0
106,000
102,249
106,000
106,000
106,000
106,000106,000106,000102,249106,0000063,20010,6004,200057,00067,13568,32871,600138,10093,40095,60012,00052,30011,80010,20011,70026,3008,1001,100
   > Long-term Liabilities 
0
0
0
365,662
329,913
294,262
294,289
443,834
481,181
407,481
300,120
327,553
274,453
534,495
506,363
507,586
534,619
545,317
514,143
460,561
459,244
465,780
466,666
462,357
458,506
452,654
452,654458,506462,357466,666465,780459,244460,561514,143545,317534,619507,586506,363534,495274,453327,553300,120407,481481,181443,834294,289294,262329,913365,662000
       Capital Lease Obligations 
0
0
0
81,354
83,579
87,102
87,297
82,391
91,561
92,981
92,033
93,406
94,045
99,276
100,542
102,196
106,654
105,902
103,025
85,279
85,420
87,989
89,037
88,504
85,454
85,764
85,76485,45488,50489,03787,98985,42085,279103,025105,902106,654102,196100,54299,27694,04593,40692,03392,98191,56182,39187,29787,10283,57981,354000
       Long-term Liabilities Other 
0
0
0
6,089
6,053
6,002
4,905
8,966
26,857
44,386
33,622
32,814
31,886
31,991
4,979
4,923
13,408
13,873
4,808
4,781
1,629
1,651
818
828
845
886
8868458288181,6511,6294,7814,80813,87313,4084,9234,97931,99131,88632,81433,62244,38626,8578,9664,9056,0026,0536,089000
> Total Stockholder Equity
407,953
444,143
481,582
520,246
561,781
602,564
640,450
679,197
720,851
756,205
809,224
788,153
874,272
905,264
931,351
966,758
985,646
1,015,739
1,051,573
1,079,117
1,006,782
1,039,908
1,066,514
1,088,183
1,125,204
1,147,764
1,147,7641,125,2041,088,1831,066,5141,039,9081,006,7821,079,1171,051,5731,015,739985,646966,758931,351905,264874,272788,153809,224756,205720,851679,197640,450602,564561,781520,246481,582444,143407,953
   Common Stock
36
36
36
36
36
37
37
37
37
37
38
38
38
38
38
38
38
38
38
38
0
0
0
0
0
0
0000003838383838383838383837373737373636363636
   Retained Earnings 
60,712
92,089
119,550
150,854
184,596
218,728
246,383
278,185
312,859
384,840
429,991
479,861
560,010
605,016
639,063
670,734
700,313
725,955
757,672
782,918
702,643
728,603
747,925
762,325
794,626
811,537
811,537794,626762,325747,925728,603702,643782,918757,672725,955700,313670,734639,063605,016560,010479,861429,991384,840312,859278,185246,383218,728184,596150,854119,55092,08960,712
   Capital Surplus 00000000000000000000000000
   Treasury Stock00000000000000000000000000
   Other Stockholders Equity 
15
15
15
15
15
15
15
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000015151515151515



6.3. Balance Sheets

Currency in USD. All numbers in thousands.




6.4. Cash Flows

Currency in USD. All numbers in thousands.




6.5. Income Statements

Currency in USD. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue2,236,382
Cost of Revenue-1,245,509
Gross Profit990,873990,873
 
Operating Income (+$)
Gross Profit990,873
Operating Expense-2,043,316
Operating Income193,066-1,052,443
 
Operating Expense (+$)
Research Development-
Selling General Administrative780,060
Selling And Marketing Expenses-
Operating Expense2,043,316780,060
 
Net Interest Income (+$)
Interest Income3,270
Interest Expense-31,274
Other Finance Cost-0
Net Interest Income-28,004
 
Pretax Income (+$)
Operating Income193,066
Net Interest Income-28,004
Other Non-Operating Income Expenses-
Income Before Tax (EBT)39,623318,505
EBIT - interestExpense = -31,274
-9,747
21,527
Interest Expense31,274
Earnings Before Interest and Taxes (EBIT)-70,897
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax39,623
Tax Provision-50,559
Net Income From Continuing Ops-10,936-10,936
Net Income-9,747
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-125,43928,004
 

Technical Analysis of Amedisys
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Amedisys. The general trend of Amedisys is BULLISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Amedisys's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (42.9%) Bearish trend (-42.9%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Amedisys Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: .

The bearish price targets are: 85.50 > 80.50 > 79.00.

Tweet this
Amedisys Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Amedisys Inc. The current mas is .

The long score for the Moving Averages is 10/14.
The longshort score for the Moving Averages is 6/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Amedisys Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Amedisys Inc. The current macd is 0.88806396.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Amedisys price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Amedisys. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Amedisys price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Amedisys Inc Daily Moving Average Convergence/Divergence (MACD) ChartAmedisys Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Amedisys Inc. The current adx is 27.85.

The long score for the Directional Movement Index (DMI) is 4/7.
The longshort score for the Directional Movement Index (DMI) is 4/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Amedisys shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bullish trend. The ADX is trending up, so the bullish trend is strengthening.
Amedisys Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Amedisys Inc. The current sar is 86.66.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Amedisys Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Amedisys Inc. The current rsi is 53.68. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 3/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
Amedisys Inc Daily Relative Strength Index (RSI) ChartAmedisys Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Amedisys Inc. The current phase is Correction in bull market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Amedisys price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Amedisys Inc Daily Stochastic Oscillator ChartAmedisys Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Amedisys Inc. The current cci is -20.26049204.

Amedisys Inc Daily Commodity Channel Index (CCI) ChartAmedisys Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Amedisys Inc. The current cmo is 2.88902035.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Amedisys Inc Daily Chande Momentum Oscillator (CMO) ChartAmedisys Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Amedisys Inc. The current willr is -75.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Amedisys is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Amedisys Inc Daily Williams %R ChartAmedisys Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Amedisys Inc.

Amedisys Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Amedisys Inc. The current atr is 0.89742355.

Amedisys Inc Daily Average True Range (ATR) ChartAmedisys Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Amedisys Inc. The current obv is -183.

Amedisys Inc Daily On-Balance Volume (OBV) ChartAmedisys Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Amedisys Inc. The current mfi is 34.95.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Amedisys Inc Daily Money Flow Index (MFI) ChartAmedisys Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Amedisys Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-09-10 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-11 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-13 00:00:00ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-16 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-17 00:00:00SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-18 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-20 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-25 00:00:00BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-26 00:00:00ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-30 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-03 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-07 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-08 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-09 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-10 00:00:00BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-11 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-14 00:00:00ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-15 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-10-16 00:00:00MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-10-17 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-21 00:00:00BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-10-28 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-30 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-31 00:00:00ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-01 00:00:00CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-04 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-05 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-06 00:00:00SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-07 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-11-08 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-11-11 00:00:00WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-11-12 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-13 00:00:00BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-14 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-15 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-19 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-11-20 00:00:00MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-11-22 00:00:00MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-11-25 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-11-26 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-11-29 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-12-02 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-12-04 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-05 00:00:00ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-06 00:00:00RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-12-09 00:00:00WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-12-10 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-11 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-16 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-20 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-23 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-12-27 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-12-30 00:00:00CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-01-02 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-08 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-10 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-01-13 00:00:00ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-14 00:00:00MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-01-23 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-01-24 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-27 00:00:00SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-01-28 00:00:00CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-01-29 00:00:00SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-30 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).

6.3. Candlestick Patterns

Amedisys Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Amedisys Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5053.683
Ma 20Greater thanMa 5087.725
Ma 50Greater thanMa 10084.700
Ma 100Greater thanMa 20085.595
OpenGreater thanClose87.500
Total2/5 (40.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Amedisys with someone you think should read this too:
  • Are you bullish or bearish on Amedisys? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Amedisys? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Amedisys Inc

I send you an email if I find something interesting about Amedisys Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Amedisys Inc.

Receive notifications about Amedisys Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.